SCHEMBL16274176

SCHEMBL16274176

Oc1ncnc2sc3c(c12)CCC3

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 3/20 0.66
ALDH1A1 P00352 10/20 0.60
KDM4E B2RXH2 6/20 0.60
MAPT P10636 4/20 0.60
GAA P10253 3/20 0.60
HTT P42858 6/20 0.55
LMNA P02545 3/20 0.55
POLB P06746 3/20 0.55
HPGD P15428 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPK1 P28482 4/20 0.54
TSHR P16473 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL923855 0.97 LIMK1 (0.66) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL13644123 0.79 LIMK1 (0.66) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL11742 0.79 LIMK1 (0.66) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL13644114 0.79 LIMK1 (1.00) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL10343525 0.79 LIMK1 (0.66) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL14115112 0.79 HTT (0.62) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL14781542 0.78 LIMK1 (0.41) LIMK1ALDH1A1KDM4EMAPTGAA
SCHEMBL15933915 0.76 LIMK1 (0.70) LIMK1ALDH1A1KDM4EMAPTHTT
SCHEMBL15533548 0.76 LIMK1 (0.70) LIMK1ALDH1A1KDM4EMAPTHTT
SCHEMBL735589 0.76 LIMK1 (0.66) LIMK1ALDH1A1KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11413278-B2 Compounds and methods for promoting stress resistance THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-08-16 US disclosed
WO-2014194242-A2 FLT3 INHIBITORS AND USES THEREOF NIMBUS IRIS, INC. (US) 2014-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11413278-B2 Compounds and methods for promoting stress resistance HSPA9, ATF4, GPX4 LIMK1 3207/4885ALDH1A1 1459/4885KDM4E 4057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.